Bester AC - Search Results

1

Impaired replication stress response in cells from immunodeficiency patients carrying Cernunnos/XLF mutations.

Schwartz M, Oren YS, Bester AC, Rahat A, Sfez R, Yitzchaik S, de Villartay JP, Kerem B. Schwartz M, et al. Among authors: bester ac. PLoS One. 2009;4(2):e4516. doi: 10.1371/journal.pone.0004516. Epub 2009 Feb 18. PLoS One. 2009. PMID: 19223975 Free PMC article.

2

Nucleotide deficiency promotes genomic instability in early stages of cancer development.

Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B. Bester AC, et al. Cell. 2011 Apr 29;145(3):435-46. doi: 10.1016/j.cell.2011.03.044. Cell. 2011. PMID: 21529715 Free PMC article.

3

Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites.

Ozeri-Galai E, Lebofsky R, Rahat A, Bester AC, Bensimon A, Kerem B. Ozeri-Galai E, et al. Among authors: bester ac. Mol Cell. 2011 Jul 8;43(1):122-31. doi: 10.1016/j.molcel.2011.05.019. Mol Cell. 2011. PMID: 21726815 Free article.

4

The complex basis underlying common fragile site instability in cancer.

Ozeri-Galai E, Bester AC, Kerem B. Ozeri-Galai E, et al. Among authors: bester ac. Trends Genet. 2012 Jun;28(6):295-302. doi: 10.1016/j.tig.2012.02.006. Epub 2012 Mar 31. Trends Genet. 2012. PMID: 22465609 Review.

5

Infection with retroviral vectors leads to perturbed DNA replication increasing vector integrations into fragile sites.

Bester AC, Kafri M, Maoz K, Kerem B. Bester AC, et al. Sci Rep. 2013;3:2189. doi: 10.1038/srep02189. Sci Rep. 2013. PMID: 23852038 Free PMC article.

6

Folate levels modulate oncogene-induced replication stress and tumorigenicity.

Lamm N, Maoz K, Bester AC, Im MM, Shewach DS, Karni R, Kerem B. Lamm N, et al. Among authors: bester ac. EMBO Mol Med. 2015 Sep;7(9):1138-52. doi: 10.15252/emmm.201404824. EMBO Mol Med. 2015. PMID: 26197802 Free PMC article.

7

The unfolded protein response affects readthrough of premature termination codons.

Oren YS, McClure ML, Rowe SM, Sorscher EJ, Bester AC, Manor M, Kerem E, Rivlin J, Zahdeh F, Mann M, Geiger T, Kerem B. Oren YS, et al. Among authors: bester ac. EMBO Mol Med. 2014 May;6(5):685-701. doi: 10.1002/emmm.201303347. EMBO Mol Med. 2014. PMID: 24705877 Free PMC article.

8

Interplay between genetic and epigenetic factors governs common fragile site instability in cancer.

Ozeri-Galai E, Tur-Sinai M, Bester AC, Kerem B. Ozeri-Galai E, et al. Among authors: bester ac. Cell Mol Life Sci. 2014 Dec;71(23):4495-506. doi: 10.1007/s00018-014-1719-8. Epub 2014 Oct 9. Cell Mol Life Sci. 2014. PMID: 25297918 Free PMC article. Review.

9

Transcriptional dynamics in colorectal carcinogenesis: new insights into the role of c-Myc and miR17 in benign to cancer transformation.

Ben-David E, Bester AC, Shifman S, Kerem B. Ben-David E, et al. Among authors: bester ac. Cancer Res. 2014 Oct 1;74(19):5532-40. doi: 10.1158/0008-5472.CAN-14-0932. Epub 2014 Aug 14. Cancer Res. 2014. PMID: 25125661

10

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.

Bester AC, Schwartz M, Schmidt M, Garrigue A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Ben-Porat N, Von Kalle C, Fischer A, Kerem B. Bester AC, et al. Gene Ther. 2006 Jul;13(13):1057-9. doi: 10.1038/sj.gt.3302752. Epub 2006 Mar 2. Gene Ther. 2006. PMID: 16511518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters